nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—ALB—Captopril—systemic scleroderma	0.0712	0.136	CbGbCtD
Chlorpromazine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0569	0.109	CbGbCtD
Chlorpromazine—ALB—Mycophenolate mofetil—systemic scleroderma	0.0561	0.107	CbGbCtD
Chlorpromazine—CYP1A2—Leflunomide—systemic scleroderma	0.0543	0.104	CbGbCtD
Chlorpromazine—ABCB1—Lisinopril—systemic scleroderma	0.0498	0.0949	CbGbCtD
Chlorpromazine—ALB—Prednisone—systemic scleroderma	0.0448	0.0855	CbGbCtD
Chlorpromazine—ABCB1—Captopril—systemic scleroderma	0.0373	0.0711	CbGbCtD
Chlorpromazine—CYP2D6—Captopril—systemic scleroderma	0.0351	0.067	CbGbCtD
Chlorpromazine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0293	0.056	CbGbCtD
Chlorpromazine—HTR2B—cardial valve—systemic scleroderma	0.0235	0.161	CbGeAlD
Chlorpromazine—ABCB1—Prednisone—systemic scleroderma	0.0234	0.0447	CbGbCtD
Chlorpromazine—ALB—Methotrexate—systemic scleroderma	0.0225	0.0429	CbGbCtD
Chlorpromazine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0176	0.0335	CbGbCtD
Chlorpromazine—CYP3A4—Prednisone—systemic scleroderma	0.014	0.0268	CbGbCtD
Chlorpromazine—ABCB1—Methotrexate—systemic scleroderma	0.0118	0.0224	CbGbCtD
Chlorpromazine—HTR7—myenteric nerve plexus—systemic scleroderma	0.0115	0.0786	CbGeAlD
Chlorpromazine—HTR7—pulmonary artery—systemic scleroderma	0.00813	0.0556	CbGeAlD
Chlorpromazine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00716	0.049	CbGeAlD
Chlorpromazine—HTR2A—pulmonary artery—systemic scleroderma	0.00507	0.0347	CbGeAlD
Chlorpromazine—SMPD1—connective tissue—systemic scleroderma	0.0034	0.0233	CbGeAlD
Chlorpromazine—CALM2—artery—systemic scleroderma	0.0031	0.0212	CbGeAlD
Chlorpromazine—CALM1—artery—systemic scleroderma	0.00309	0.0211	CbGeAlD
Chlorpromazine—SMPD1—skin of body—systemic scleroderma	0.00307	0.021	CbGeAlD
Chlorpromazine—HTR7—artery—systemic scleroderma	0.00302	0.0206	CbGeAlD
Chlorpromazine—CALM2—endothelium—systemic scleroderma	0.00262	0.0179	CbGeAlD
Chlorpromazine—CALM1—endothelium—systemic scleroderma	0.00261	0.0178	CbGeAlD
Chlorpromazine—HTR7—endothelium—systemic scleroderma	0.00255	0.0174	CbGeAlD
Chlorpromazine—SMPD1—digestive system—systemic scleroderma	0.00246	0.0168	CbGeAlD
Chlorpromazine—CALM2—blood vessel—systemic scleroderma	0.00242	0.0165	CbGeAlD
Chlorpromazine—CALM1—blood vessel—systemic scleroderma	0.0024	0.0164	CbGeAlD
Chlorpromazine—HTR7—blood vessel—systemic scleroderma	0.00235	0.0161	CbGeAlD
Chlorpromazine—SMPD1—tendon—systemic scleroderma	0.00234	0.016	CbGeAlD
Chlorpromazine—SMPD1—lung—systemic scleroderma	0.00205	0.014	CbGeAlD
Chlorpromazine—ABCB11—digestive system—systemic scleroderma	0.00194	0.0133	CbGeAlD
Chlorpromazine—HTR2A—artery—systemic scleroderma	0.00188	0.0129	CbGeAlD
Chlorpromazine—Jaundice cholestatic—Lisinopril—systemic scleroderma	0.0016	0.00595	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Captopril—systemic scleroderma	0.00159	0.00594	CcSEcCtD
Chlorpromazine—HTR2A—endothelium—systemic scleroderma	0.00159	0.0109	CbGeAlD
Chlorpromazine—Pancytopenia—Pentoxifylline—systemic scleroderma	0.00156	0.0058	CcSEcCtD
Chlorpromazine—Oropharyngeal pain—Lisinopril—systemic scleroderma	0.00154	0.00575	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Captopril—systemic scleroderma	0.00152	0.00568	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Captopril—systemic scleroderma	0.00149	0.00554	CcSEcCtD
Chlorpromazine—Blood disorder—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00548	CcSEcCtD
Chlorpromazine—HTR2A—blood vessel—systemic scleroderma	0.00146	0.01	CbGeAlD
Chlorpromazine—Drowsiness—Pentoxifylline—systemic scleroderma	0.00146	0.00545	CcSEcCtD
Chlorpromazine—CALM3—smooth muscle tissue—systemic scleroderma	0.00144	0.00987	CbGeAlD
Chlorpromazine—Jaundice—Pentoxifylline—systemic scleroderma	0.00143	0.00531	CcSEcCtD
Chlorpromazine—Influenza—Mometasone—systemic scleroderma	0.00142	0.00527	CcSEcCtD
Chlorpromazine—Asthma—Mometasone—systemic scleroderma	0.00142	0.00527	CcSEcCtD
Chlorpromazine—Amenorrhoea—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00521	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00521	CcSEcCtD
Chlorpromazine—Cardiac arrest—Captopril—systemic scleroderma	0.00137	0.0051	CcSEcCtD
Chlorpromazine—Sudden death—Methotrexate—systemic scleroderma	0.00136	0.00507	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Captopril—systemic scleroderma	0.00131	0.00489	CcSEcCtD
Chlorpromazine—HTR2B—smooth muscle tissue—systemic scleroderma	0.00129	0.0088	CbGeAlD
Chlorpromazine—HTR2B—skin of body—systemic scleroderma	0.00127	0.00869	CbGeAlD
Chlorpromazine—CALM2—connective tissue—systemic scleroderma	0.00124	0.00847	CbGeAlD
Chlorpromazine—CALM1—connective tissue—systemic scleroderma	0.00123	0.00843	CbGeAlD
Chlorpromazine—Eosinophilia—Captopril—systemic scleroderma	0.00123	0.00459	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.00122	0.00456	CcSEcCtD
Chlorpromazine—HTR7—connective tissue—systemic scleroderma	0.0012	0.00824	CbGeAlD
Chlorpromazine—Pancytopenia—Captopril—systemic scleroderma	0.00118	0.0044	CcSEcCtD
Chlorpromazine—Photosensitivity—Lisinopril—systemic scleroderma	0.00116	0.00432	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.00116	0.00432	CcSEcCtD
Chlorpromazine—CHRM3—smooth muscle tissue—systemic scleroderma	0.00116	0.00792	CbGeAlD
Chlorpromazine—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00115	0.0043	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Captopril—systemic scleroderma	0.00114	0.00427	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Captopril—systemic scleroderma	0.00113	0.00423	CcSEcCtD
Chlorpromazine—CALM2—smooth muscle tissue—systemic scleroderma	0.00113	0.00775	CbGeAlD
Chlorpromazine—Haemolytic anaemia—Lisinopril—systemic scleroderma	0.00113	0.0042	CcSEcCtD
Chlorpromazine—CALM1—smooth muscle tissue—systemic scleroderma	0.00113	0.00771	CbGeAlD
Chlorpromazine—CALM2—skin of body—systemic scleroderma	0.00112	0.00765	CbGeAlD
Chlorpromazine—Nasal congestion—Lisinopril—systemic scleroderma	0.00112	0.00417	CcSEcCtD
Chlorpromazine—CALM1—skin of body—systemic scleroderma	0.00111	0.00761	CbGeAlD
Chlorpromazine—Nervousness—Pentoxifylline—systemic scleroderma	0.00111	0.00414	CcSEcCtD
Chlorpromazine—HTR7—smooth muscle tissue—systemic scleroderma	0.0011	0.00754	CbGeAlD
Chlorpromazine—Gynaecomastia—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0041	CcSEcCtD
Chlorpromazine—Muscle spasms—Pentoxifylline—systemic scleroderma	0.0011	0.00409	CcSEcCtD
Chlorpromazine—CALM3—tendon—systemic scleroderma	0.00108	0.00742	CbGeAlD
Chlorpromazine—Jaundice—Captopril—systemic scleroderma	0.00108	0.00403	CcSEcCtD
Chlorpromazine—Cardiac arrest—Mycophenolic acid—systemic scleroderma	0.00108	0.00401	CcSEcCtD
Chlorpromazine—Urinary retention—Mycophenolic acid—systemic scleroderma	0.00108	0.00401	CcSEcCtD
Chlorpromazine—Tremor—Pentoxifylline—systemic scleroderma	0.00107	0.00399	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.00105	0.00392	CcSEcCtD
Chlorpromazine—Angioedema—Pentoxifylline—systemic scleroderma	0.00104	0.00389	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Lisinopril—systemic scleroderma	0.00104	0.00389	CcSEcCtD
Chlorpromazine—Agranulocytosis—Captopril—systemic scleroderma	0.00103	0.00385	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00103	0.00385	CcSEcCtD
Chlorpromazine—Pancytopenia—Azathioprine—systemic scleroderma	0.00103	0.00384	CcSEcCtD
Chlorpromazine—Glycosuria—Prednisone—systemic scleroderma	0.00103	0.00383	CcSEcCtD
Chlorpromazine—Asthma—Leflunomide—systemic scleroderma	0.00102	0.00382	CcSEcCtD
Chlorpromazine—Influenza—Leflunomide—systemic scleroderma	0.00102	0.00382	CcSEcCtD
Chlorpromazine—Leukopenia—Pentoxifylline—systemic scleroderma	0.00102	0.00381	CcSEcCtD
Chlorpromazine—HTR2B—digestive system—systemic scleroderma	0.00102	0.00695	CbGeAlD
Chlorpromazine—Eosinophilia—Leflunomide—systemic scleroderma	0.00101	0.00378	CcSEcCtD
Chlorpromazine—Endocrine disorder—Prednisone—systemic scleroderma	0.00101	0.00375	CcSEcCtD
Chlorpromazine—Convulsion—Pentoxifylline—systemic scleroderma	0.00099	0.00369	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.000989	0.00368	CcSEcCtD
Chlorpromazine—Dysphagia—Mycophenolic acid—systemic scleroderma	0.000977	0.00364	CcSEcCtD
Chlorpromazine—Influenza—Mycophenolic acid—systemic scleroderma	0.000977	0.00364	CcSEcCtD
Chlorpromazine—Asthma—Mycophenolic acid—systemic scleroderma	0.000977	0.00364	CcSEcCtD
Chlorpromazine—Pancytopenia—Leflunomide—systemic scleroderma	0.000973	0.00363	CcSEcCtD
Chlorpromazine—Cardiac arrest—Lisinopril—systemic scleroderma	0.000968	0.00361	CcSEcCtD
Chlorpromazine—HTR2B—tendon—systemic scleroderma	0.000967	0.00661	CbGeAlD
Chlorpromazine—ABCB1—blood vessel—systemic scleroderma	0.00096	0.00657	CbGeAlD
Chlorpromazine—Dry mouth—Pentoxifylline—systemic scleroderma	0.000952	0.00355	CcSEcCtD
Chlorpromazine—CALM3—lung—systemic scleroderma	0.000951	0.00651	CbGeAlD
Chlorpromazine—Amenorrhoea—Prednisone—systemic scleroderma	0.000948	0.00353	CcSEcCtD
Chlorpromazine—BCHE—smooth muscle tissue—systemic scleroderma	0.000945	0.00646	CbGeAlD
Chlorpromazine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.000933	0.00348	CcSEcCtD
Chlorpromazine—BCHE—skin of body—systemic scleroderma	0.000933	0.00638	CbGeAlD
Chlorpromazine—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00093	0.00347	CcSEcCtD
Chlorpromazine—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.000928	0.00346	CcSEcCtD
Chlorpromazine—Infection—Pentoxifylline—systemic scleroderma	0.000927	0.00345	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Leflunomide—systemic scleroderma	0.000924	0.00344	CcSEcCtD
Chlorpromazine—Shock—Pentoxifylline—systemic scleroderma	0.000918	0.00342	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000914	0.00341	CcSEcCtD
Chlorpromazine—CHRM3—digestive system—systemic scleroderma	0.000914	0.00625	CbGeAlD
Chlorpromazine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00091	0.00339	CcSEcCtD
Chlorpromazine—Agranulocytosis—Azathioprine—systemic scleroderma	0.000903	0.00336	CcSEcCtD
Chlorpromazine—Angioedema—Mometasone—systemic scleroderma	0.000901	0.00336	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.0009	0.00335	CcSEcCtD
Chlorpromazine—HRH1—connective tissue—systemic scleroderma	0.000899	0.00615	CbGeAlD
Chlorpromazine—CALM2—digestive system—systemic scleroderma	0.000895	0.00612	CbGeAlD
Chlorpromazine—CALM1—digestive system—systemic scleroderma	0.000891	0.00609	CbGeAlD
Chlorpromazine—Jaundice—Leflunomide—systemic scleroderma	0.00089	0.00332	CcSEcCtD
Chlorpromazine—ADRA2A—connective tissue—systemic scleroderma	0.000883	0.00604	CbGeAlD
Chlorpromazine—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.000882	0.00328	CcSEcCtD
Chlorpromazine—Asthma—Lisinopril—systemic scleroderma	0.00088	0.00328	CcSEcCtD
Chlorpromazine—Influenza—Lisinopril—systemic scleroderma	0.00088	0.00328	CcSEcCtD
Chlorpromazine—Eosinophilia—Lisinopril—systemic scleroderma	0.000872	0.00325	CcSEcCtD
Chlorpromazine—Hypotension—Pentoxifylline—systemic scleroderma	0.000872	0.00325	CcSEcCtD
Chlorpromazine—HTR7—digestive system—systemic scleroderma	0.00087	0.00595	CbGeAlD
Chlorpromazine—Cough—Mometasone—systemic scleroderma	0.000861	0.00321	CcSEcCtD
Chlorpromazine—CHRM1—lung—systemic scleroderma	0.000853	0.00583	CbGeAlD
Chlorpromazine—Agranulocytosis—Leflunomide—systemic scleroderma	0.000852	0.00318	CcSEcCtD
Chlorpromazine—CALM2—tendon—systemic scleroderma	0.000851	0.00582	CbGeAlD
Chlorpromazine—Jaundice—Mycophenolic acid—systemic scleroderma	0.000849	0.00316	CcSEcCtD
Chlorpromazine—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.000849	0.00316	CcSEcCtD
Chlorpromazine—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.000849	0.00316	CcSEcCtD
Chlorpromazine—HTR2B—lung—systemic scleroderma	0.000848	0.0058	CbGeAlD
Chlorpromazine—CALM1—tendon—systemic scleroderma	0.000848	0.0058	CbGeAlD
Chlorpromazine—Insomnia—Pentoxifylline—systemic scleroderma	0.000844	0.00314	CcSEcCtD
Chlorpromazine—Nervousness—Captopril—systemic scleroderma	0.000841	0.00313	CcSEcCtD
Chlorpromazine—Pancytopenia—Lisinopril—systemic scleroderma	0.000836	0.00311	CcSEcCtD
Chlorpromazine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.000832	0.0031	CcSEcCtD
Chlorpromazine—Somnolence—Pentoxifylline—systemic scleroderma	0.000829	0.00309	CcSEcCtD
Chlorpromazine—HTR7—tendon—systemic scleroderma	0.000828	0.00566	CbGeAlD
Chlorpromazine—HRH1—smooth muscle tissue—systemic scleroderma	0.000823	0.00563	CbGeAlD
Chlorpromazine—Dry mouth—Mometasone—systemic scleroderma	0.000821	0.00306	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.000815	0.00304	CcSEcCtD
Chlorpromazine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.000813	0.00303	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Lisinopril—systemic scleroderma	0.000811	0.00302	CcSEcCtD
Chlorpromazine—Oedema peripheral—Leflunomide—systemic scleroderma	0.000808	0.00301	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Mometasone—systemic scleroderma	0.000805	0.003	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.000804	0.00299	CcSEcCtD
Chlorpromazine—Infection—Mometasone—systemic scleroderma	0.0008	0.00298	CcSEcCtD
Chlorpromazine—Constipation—Pentoxifylline—systemic scleroderma	0.000798	0.00297	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Lisinopril—systemic scleroderma	0.000794	0.00296	CcSEcCtD
Chlorpromazine—Angioedema—Captopril—systemic scleroderma	0.000791	0.00295	CcSEcCtD
Chlorpromazine—Syncope—Captopril—systemic scleroderma	0.000777	0.00289	CcSEcCtD
Chlorpromazine—Asthma—Mycophenolate mofetil—systemic scleroderma	0.000771	0.00287	CcSEcCtD
Chlorpromazine—Influenza—Mycophenolate mofetil—systemic scleroderma	0.000771	0.00287	CcSEcCtD
Chlorpromazine—Dysphagia—Mycophenolate mofetil—systemic scleroderma	0.000771	0.00287	CcSEcCtD
Chlorpromazine—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.000771	0.00287	CcSEcCtD
Chlorpromazine—Jaundice—Lisinopril—systemic scleroderma	0.000765	0.00285	CcSEcCtD
Chlorpromazine—Loss of consciousness—Captopril—systemic scleroderma	0.000761	0.00284	CcSEcCtD
Chlorpromazine—Cough—Captopril—systemic scleroderma	0.000756	0.00282	CcSEcCtD
Chlorpromazine—Visual impairment—Mycophenolic acid—systemic scleroderma	0.000754	0.00281	CcSEcCtD
Chlorpromazine—HTR2A—connective tissue—systemic scleroderma	0.000751	0.00514	CbGeAlD
Chlorpromazine—CALM2—lung—systemic scleroderma	0.000747	0.00511	CbGeAlD
Chlorpromazine—BCHE—digestive system—systemic scleroderma	0.000746	0.0051	CbGeAlD
Chlorpromazine—CALM1—lung—systemic scleroderma	0.000744	0.00509	CbGeAlD
Chlorpromazine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000737	0.00275	CcSEcCtD
Chlorpromazine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.000732	0.00273	CcSEcCtD
Chlorpromazine—Agranulocytosis—Lisinopril—systemic scleroderma	0.000732	0.00273	CcSEcCtD
Chlorpromazine—HTR7—lung—systemic scleroderma	0.000727	0.00497	CbGeAlD
Chlorpromazine—Dry mouth—Captopril—systemic scleroderma	0.000721	0.00269	CcSEcCtD
Chlorpromazine—Dyspnoea—Mometasone—systemic scleroderma	0.000718	0.00267	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00071	0.00265	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Captopril—systemic scleroderma	0.000707	0.00263	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000696	0.00259	CcSEcCtD
Chlorpromazine—Shock—Captopril—systemic scleroderma	0.000695	0.00259	CcSEcCtD
Chlorpromazine—Oedema peripheral—Lisinopril—systemic scleroderma	0.000694	0.00259	CcSEcCtD
Chlorpromazine—CYP1A2—digestive system—systemic scleroderma	0.000694	0.00475	CbGeAlD
Chlorpromazine—Tachycardia—Captopril—systemic scleroderma	0.00069	0.00257	CcSEcCtD
Chlorpromazine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000687	0.00256	CcSEcCtD
Chlorpromazine—HTR2A—smooth muscle tissue—systemic scleroderma	0.000687	0.0047	CbGeAlD
Chlorpromazine—DRD2—lung—systemic scleroderma	0.000687	0.0047	CbGeAlD
Chlorpromazine—Muscle spasms—Leflunomide—systemic scleroderma	0.000686	0.00256	CcSEcCtD
Chlorpromazine—Leukopenia—Azathioprine—systemic scleroderma	0.000677	0.00252	CcSEcCtD
Chlorpromazine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00067	0.0025	CcSEcCtD
Chlorpromazine—Nervousness—Mycophenolic acid—systemic scleroderma	0.000661	0.00246	CcSEcCtD
Chlorpromazine—Hypotension—Captopril—systemic scleroderma	0.000661	0.00246	CcSEcCtD
Chlorpromazine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000655	0.00244	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000654	0.00244	CcSEcCtD
Chlorpromazine—Angioedema—Leflunomide—systemic scleroderma	0.000652	0.00243	CcSEcCtD
Chlorpromazine—HRH1—digestive system—systemic scleroderma	0.00065	0.00444	CbGeAlD
Chlorpromazine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000642	0.00239	CcSEcCtD
Chlorpromazine—Insomnia—Captopril—systemic scleroderma	0.000639	0.00238	CcSEcCtD
Chlorpromazine—Leukopenia—Leflunomide—systemic scleroderma	0.000639	0.00238	CcSEcCtD
Chlorpromazine—Tremor—Mycophenolic acid—systemic scleroderma	0.000638	0.00238	CcSEcCtD
Chlorpromazine—Body temperature increased—Mometasone—systemic scleroderma	0.000636	0.00237	CcSEcCtD
Chlorpromazine—Dyspnoea—Captopril—systemic scleroderma	0.00063	0.00235	CcSEcCtD
Chlorpromazine—Somnolence—Captopril—systemic scleroderma	0.000628	0.00234	CcSEcCtD
Chlorpromazine—CYP2E1—digestive system—systemic scleroderma	0.000624	0.00427	CbGeAlD
Chlorpromazine—Gynaecomastia—Methotrexate—systemic scleroderma	0.000623	0.00232	CcSEcCtD
Chlorpromazine—BCHE—lung—systemic scleroderma	0.000623	0.00426	CbGeAlD
Chlorpromazine—Cough—Leflunomide—systemic scleroderma	0.000623	0.00232	CcSEcCtD
Chlorpromazine—HRH1—tendon—systemic scleroderma	0.000618	0.00423	CbGeAlD
Chlorpromazine—Dizziness—Pentoxifylline—systemic scleroderma	0.000617	0.0023	CcSEcCtD
Chlorpromazine—Infection—Azathioprine—systemic scleroderma	0.000613	0.00228	CcSEcCtD
Chlorpromazine—Syncope—Mycophenolic acid—systemic scleroderma	0.000611	0.00228	CcSEcCtD
Chlorpromazine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00061	0.00227	CcSEcCtD
Chlorpromazine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000608	0.00227	CcSEcCtD
Chlorpromazine—ADRA2A—tendon—systemic scleroderma	0.000607	0.00415	CbGeAlD
Chlorpromazine—Constipation—Captopril—systemic scleroderma	0.000604	0.00225	CcSEcCtD
Chlorpromazine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000599	0.00223	CcSEcCtD
Chlorpromazine—Nervousness—Lisinopril—systemic scleroderma	0.000596	0.00222	CcSEcCtD
Chlorpromazine—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000595	0.00222	CcSEcCtD
Chlorpromazine—Dry mouth—Leflunomide—systemic scleroderma	0.000594	0.00221	CcSEcCtD
Chlorpromazine—Cough—Mycophenolic acid—systemic scleroderma	0.000594	0.00221	CcSEcCtD
Chlorpromazine—CYP2E1—tendon—systemic scleroderma	0.000594	0.00406	CbGeAlD
Chlorpromazine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00059	0.0022	CcSEcCtD
Chlorpromazine—Muscle spasms—Lisinopril—systemic scleroderma	0.00059	0.0022	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000583	0.00217	CcSEcCtD
Chlorpromazine—CYP1A2—lung—systemic scleroderma	0.000579	0.00396	CbGeAlD
Chlorpromazine—Infection—Leflunomide—systemic scleroderma	0.000579	0.00216	CcSEcCtD
Chlorpromazine—Hypotension—Azathioprine—systemic scleroderma	0.000576	0.00215	CcSEcCtD
Chlorpromazine—Photosensitivity—Methotrexate—systemic scleroderma	0.000576	0.00215	CcSEcCtD
Chlorpromazine—Cardiac arrest—Prednisone—systemic scleroderma	0.000575	0.00214	CcSEcCtD
Chlorpromazine—Tremor—Lisinopril—systemic scleroderma	0.000575	0.00214	CcSEcCtD
Chlorpromazine—Tachycardia—Leflunomide—systemic scleroderma	0.000569	0.00212	CcSEcCtD
Chlorpromazine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000567	0.00211	CcSEcCtD
Chlorpromazine—Angioedema—Lisinopril—systemic scleroderma	0.00056	0.00209	CcSEcCtD
Chlorpromazine—Body temperature increased—Captopril—systemic scleroderma	0.000559	0.00208	CcSEcCtD
Chlorpromazine—Infection—Mycophenolic acid—systemic scleroderma	0.000552	0.00206	CcSEcCtD
Chlorpromazine—Syncope—Lisinopril—systemic scleroderma	0.00055	0.00205	CcSEcCtD
Chlorpromazine—Leukopenia—Lisinopril—systemic scleroderma	0.000549	0.00205	CcSEcCtD
Chlorpromazine—Shock—Mycophenolic acid—systemic scleroderma	0.000547	0.00204	CcSEcCtD
Chlorpromazine—Hypotension—Leflunomide—systemic scleroderma	0.000544	0.00203	CcSEcCtD
Chlorpromazine—HTR2A—digestive system—systemic scleroderma	0.000543	0.00371	CbGeAlD
Chlorpromazine—HRH1—lung—systemic scleroderma	0.000542	0.00371	CbGeAlD
Chlorpromazine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000542	0.00202	CcSEcCtD
Chlorpromazine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000539	0.00201	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000536	0.002	CcSEcCtD
Chlorpromazine—Cough—Lisinopril—systemic scleroderma	0.000535	0.00199	CcSEcCtD
Chlorpromazine—ADRA2A—lung—systemic scleroderma	0.000533	0.00364	CbGeAlD
Chlorpromazine—Insomnia—Leflunomide—systemic scleroderma	0.000527	0.00196	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000522	0.00195	CcSEcCtD
Chlorpromazine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000522	0.00194	CcSEcCtD
Chlorpromazine—CYP2E1—lung—systemic scleroderma	0.000521	0.00357	CbGeAlD
Chlorpromazine—Dyspnoea—Leflunomide—systemic scleroderma	0.000519	0.00194	CcSEcCtD
Chlorpromazine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000519	0.00193	CcSEcCtD
Chlorpromazine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000517	0.00193	CcSEcCtD
Chlorpromazine—HTR2A—tendon—systemic scleroderma	0.000516	0.00353	CbGeAlD
Chlorpromazine—Dry mouth—Lisinopril—systemic scleroderma	0.000511	0.0019	CcSEcCtD
Chlorpromazine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000504	0.00188	CcSEcCtD
Chlorpromazine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000503	0.00187	CcSEcCtD
Chlorpromazine—CYP3A4—digestive system—systemic scleroderma	0.000502	0.00343	CbGeAlD
Chlorpromazine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000501	0.00187	CcSEcCtD
Chlorpromazine—Constipation—Leflunomide—systemic scleroderma	0.000498	0.00186	CcSEcCtD
Chlorpromazine—Infection—Lisinopril—systemic scleroderma	0.000497	0.00185	CcSEcCtD
Chlorpromazine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000496	0.00185	CcSEcCtD
Chlorpromazine—CYP2D6—digestive system—systemic scleroderma	0.000494	0.00338	CbGeAlD
Chlorpromazine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000494	0.00184	CcSEcCtD
Chlorpromazine—Shock—Lisinopril—systemic scleroderma	0.000493	0.00184	CcSEcCtD
Chlorpromazine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00183	CcSEcCtD
Chlorpromazine—Tachycardia—Lisinopril—systemic scleroderma	0.000489	0.00182	CcSEcCtD
Chlorpromazine—Body temperature increased—Azathioprine—systemic scleroderma	0.000488	0.00182	CcSEcCtD
Chlorpromazine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000482	0.0018	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000482	0.00179	CcSEcCtD
Chlorpromazine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000481	0.00179	CcSEcCtD
Chlorpromazine—Constipation—Mycophenolic acid—systemic scleroderma	0.000475	0.00177	CcSEcCtD
Chlorpromazine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00176	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000472	0.00176	CcSEcCtD
Chlorpromazine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000469	0.00175	CcSEcCtD
Chlorpromazine—Hypotension—Lisinopril—systemic scleroderma	0.000468	0.00174	CcSEcCtD
Chlorpromazine—Dizziness—Captopril—systemic scleroderma	0.000467	0.00174	CcSEcCtD
Chlorpromazine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000466	0.00173	CcSEcCtD
Chlorpromazine—Body temperature increased—Leflunomide—systemic scleroderma	0.000461	0.00172	CcSEcCtD
Chlorpromazine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000455	0.00169	CcSEcCtD
Chlorpromazine—HTR2A—lung—systemic scleroderma	0.000453	0.0031	CbGeAlD
Chlorpromazine—Insomnia—Lisinopril—systemic scleroderma	0.000453	0.00169	CcSEcCtD
Chlorpromazine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00167	CcSEcCtD
Chlorpromazine—Dyspnoea—Lisinopril—systemic scleroderma	0.000446	0.00166	CcSEcCtD
Chlorpromazine—Somnolence—Lisinopril—systemic scleroderma	0.000445	0.00166	CcSEcCtD
Chlorpromazine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000439	0.00164	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000439	0.00163	CcSEcCtD
Chlorpromazine—Asthma—Methotrexate—systemic scleroderma	0.000437	0.00163	CcSEcCtD
Chlorpromazine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000436	0.00162	CcSEcCtD
Chlorpromazine—Eosinophilia—Methotrexate—systemic scleroderma	0.000433	0.00161	CcSEcCtD
Chlorpromazine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000432	0.00161	CcSEcCtD
Chlorpromazine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000429	0.0016	CcSEcCtD
Chlorpromazine—Constipation—Lisinopril—systemic scleroderma	0.000428	0.00159	CcSEcCtD
Chlorpromazine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000428	0.00159	CcSEcCtD
Chlorpromazine—Pancytopenia—Methotrexate—systemic scleroderma	0.000415	0.00155	CcSEcCtD
Chlorpromazine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00153	CcSEcCtD
Chlorpromazine—Dizziness—Azathioprine—systemic scleroderma	0.000408	0.00152	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000402	0.0015	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000399	0.00149	CcSEcCtD
Chlorpromazine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000397	0.00148	CcSEcCtD
Chlorpromazine—Body temperature increased—Lisinopril—systemic scleroderma	0.000396	0.00147	CcSEcCtD
Chlorpromazine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000391	0.00146	CcSEcCtD
Chlorpromazine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00039	0.00145	CcSEcCtD
Chlorpromazine—Drowsiness—Methotrexate—systemic scleroderma	0.00039	0.00145	CcSEcCtD
Chlorpromazine—Dizziness—Leflunomide—systemic scleroderma	0.000385	0.00144	CcSEcCtD
Chlorpromazine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000375	0.0014	CcSEcCtD
Chlorpromazine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000369	0.00137	CcSEcCtD
Chlorpromazine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000368	0.00137	CcSEcCtD
Chlorpromazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000364	0.00135	CcSEcCtD
Chlorpromazine—ABCB1—digestive system—systemic scleroderma	0.000356	0.00243	CbGeAlD
Chlorpromazine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000347	0.00129	CcSEcCtD
Chlorpromazine—Visual impairment—Methotrexate—systemic scleroderma	0.000337	0.00126	CcSEcCtD
Chlorpromazine—Angioedema—Prednisone—systemic scleroderma	0.000333	0.00124	CcSEcCtD
Chlorpromazine—Dizziness—Lisinopril—systemic scleroderma	0.000331	0.00123	CcSEcCtD
Chlorpromazine—Syncope—Prednisone—systemic scleroderma	0.000327	0.00122	CcSEcCtD
Chlorpromazine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000323	0.0012	CcSEcCtD
Chlorpromazine—Loss of consciousness—Prednisone—systemic scleroderma	0.00032	0.00119	CcSEcCtD
Chlorpromazine—Convulsion—Prednisone—systemic scleroderma	0.000316	0.00118	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000297	0.00111	CcSEcCtD
Chlorpromazine—ABCB1—lung—systemic scleroderma	0.000297	0.00203	CbGeAlD
Chlorpromazine—Infection—Prednisone—systemic scleroderma	0.000295	0.0011	CcSEcCtD
Chlorpromazine—Shock—Prednisone—systemic scleroderma	0.000293	0.00109	CcSEcCtD
Chlorpromazine—Tachycardia—Prednisone—systemic scleroderma	0.00029	0.00108	CcSEcCtD
Chlorpromazine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00029	0.00108	CcSEcCtD
Chlorpromazine—Leukopenia—Methotrexate—systemic scleroderma	0.000273	0.00102	CcSEcCtD
Chlorpromazine—Insomnia—Prednisone—systemic scleroderma	0.000269	0.001	CcSEcCtD
Chlorpromazine—Cough—Methotrexate—systemic scleroderma	0.000266	0.00099	CcSEcCtD
Chlorpromazine—Convulsion—Methotrexate—systemic scleroderma	0.000264	0.000983	CcSEcCtD
Chlorpromazine—Constipation—Prednisone—systemic scleroderma	0.000254	0.000947	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000248	0.000926	CcSEcCtD
Chlorpromazine—Infection—Methotrexate—systemic scleroderma	0.000247	0.00092	CcSEcCtD
Chlorpromazine—Body temperature increased—Prednisone—systemic scleroderma	0.000235	0.000876	CcSEcCtD
Chlorpromazine—Hypotension—Methotrexate—systemic scleroderma	0.000232	0.000865	CcSEcCtD
Chlorpromazine—Insomnia—Methotrexate—systemic scleroderma	0.000225	0.000837	CcSEcCtD
Chlorpromazine—Dyspnoea—Methotrexate—systemic scleroderma	0.000222	0.000825	CcSEcCtD
Chlorpromazine—Somnolence—Methotrexate—systemic scleroderma	0.000221	0.000823	CcSEcCtD
Chlorpromazine—Hypersensitivity—Prednisone—systemic scleroderma	0.000219	0.000816	CcSEcCtD
Chlorpromazine—Dizziness—Prednisone—systemic scleroderma	0.000197	0.000733	CcSEcCtD
Chlorpromazine—Body temperature increased—Methotrexate—systemic scleroderma	0.000196	0.000732	CcSEcCtD
Chlorpromazine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000183	0.000682	CcSEcCtD
Chlorpromazine—Dizziness—Methotrexate—systemic scleroderma	0.000164	0.000612	CcSEcCtD
Chlorpromazine—CALM1—Disease—CD247—systemic scleroderma	2.69e-05	0.000438	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—RHOB—systemic scleroderma	2.69e-05	0.000438	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—RHOB—systemic scleroderma	2.68e-05	0.000437	CbGpPWpGaD
Chlorpromazine—CALM3—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.67e-05	0.000436	CbGpPWpGaD
Chlorpromazine—DRD2—GPCR downstream signaling—EDN1—systemic scleroderma	2.65e-05	0.000432	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.64e-05	0.00043	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—HSPG2—systemic scleroderma	2.62e-05	0.000428	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—EDN1—systemic scleroderma	2.61e-05	0.000425	CbGpPWpGaD
Chlorpromazine—HTR2A—GPCR downstream signaling—EDN1—systemic scleroderma	2.6e-05	0.000425	CbGpPWpGaD
Chlorpromazine—HRH1—GPCR downstream signaling—EDN1—systemic scleroderma	2.6e-05	0.000424	CbGpPWpGaD
Chlorpromazine—CHRM1—GPCR downstream signaling—EDN1—systemic scleroderma	2.59e-05	0.000423	CbGpPWpGaD
Chlorpromazine—CALM2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.59e-05	0.000422	CbGpPWpGaD
Chlorpromazine—CALM1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.59e-05	0.000422	CbGpPWpGaD
Chlorpromazine—CHRM3—GPCR downstream signaling—EDN1—systemic scleroderma	2.58e-05	0.000421	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—HSPG2—systemic scleroderma	2.58e-05	0.000421	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—HSPG2—systemic scleroderma	2.58e-05	0.000421	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—HSPG2—systemic scleroderma	2.57e-05	0.00042	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—HSPG2—systemic scleroderma	2.57e-05	0.000419	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—HSPG2—systemic scleroderma	2.56e-05	0.000418	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—HSPG2—systemic scleroderma	2.56e-05	0.000417	CbGpPWpGaD
Chlorpromazine—CHRM2—GPCR downstream signaling—EDN1—systemic scleroderma	2.56e-05	0.000417	CbGpPWpGaD
Chlorpromazine—ADRA1A—GPCR downstream signaling—EDN1—systemic scleroderma	2.55e-05	0.000416	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—HSPG2—systemic scleroderma	2.53e-05	0.000413	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CSK—systemic scleroderma	2.53e-05	0.000413	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling by GPCR—CCL2—systemic scleroderma	2.53e-05	0.000412	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—HSPG2—systemic scleroderma	2.53e-05	0.000412	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling by GPCR—CCL2—systemic scleroderma	2.52e-05	0.000412	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—CCL2—systemic scleroderma	2.51e-05	0.00041	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—CTGF—systemic scleroderma	2.51e-05	0.00041	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CSK—systemic scleroderma	2.49e-05	0.000407	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—RHOB—systemic scleroderma	2.49e-05	0.000406	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—MMP1—systemic scleroderma	2.49e-05	0.000406	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CSK—systemic scleroderma	2.49e-05	0.000406	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CSK—systemic scleroderma	2.48e-05	0.000404	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—HSPG2—systemic scleroderma	2.48e-05	0.000404	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—HSPG2—systemic scleroderma	2.48e-05	0.000404	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CSK—systemic scleroderma	2.47e-05	0.000403	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CSK—systemic scleroderma	2.45e-05	0.000399	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CSK—systemic scleroderma	2.44e-05	0.000398	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling by GPCR—CCL2—systemic scleroderma	2.42e-05	0.000394	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—EDN1—systemic scleroderma	2.4e-05	0.000392	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR downstream signaling—EDN1—systemic scleroderma	2.37e-05	0.000387	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—EDN1—systemic scleroderma	2.36e-05	0.000386	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—EDN1—systemic scleroderma	2.36e-05	0.000385	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—EDN1—systemic scleroderma	2.35e-05	0.000384	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—HSPG2—systemic scleroderma	2.35e-05	0.000383	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—EDN1—systemic scleroderma	2.34e-05	0.000383	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—EDN1—systemic scleroderma	2.32e-05	0.000379	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—CTGF—systemic scleroderma	2.32e-05	0.000378	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—EDN1—systemic scleroderma	2.31e-05	0.000378	CbGpPWpGaD
Chlorpromazine—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.31e-05	0.000377	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling by GPCR—CCL2—systemic scleroderma	2.31e-05	0.000376	CbGpPWpGaD
Chlorpromazine—ADRA2A—Hemostasis—NOS3—systemic scleroderma	2.28e-05	0.000373	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—CTLA4—systemic scleroderma	2.28e-05	0.000372	CbGpPWpGaD
Chlorpromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	2.28e-05	0.000372	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—RHOB—systemic scleroderma	2.27e-05	0.000371	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CSK—systemic scleroderma	2.27e-05	0.00037	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—NOS3—systemic scleroderma	2.24e-05	0.000365	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—HSPG2—systemic scleroderma	2.21e-05	0.000361	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CTLA4—systemic scleroderma	2.2e-05	0.00036	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CTLA4—systemic scleroderma	2.2e-05	0.00036	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—RHOB—systemic scleroderma	2.2e-05	0.000358	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—RHOB—systemic scleroderma	2.2e-05	0.000358	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—EDN1—systemic scleroderma	2.18e-05	0.000356	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—EDN1—systemic scleroderma	2.18e-05	0.000356	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling by GPCR—CCL2—systemic scleroderma	2.18e-05	0.000355	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—EDN1—systemic scleroderma	2.15e-05	0.000351	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling by GPCR—CCL2—systemic scleroderma	2.15e-05	0.00035	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—HSPG2—systemic scleroderma	2.14e-05	0.000349	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—CTGF—systemic scleroderma	2.13e-05	0.000347	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—EDN1—systemic scleroderma	2.09e-05	0.000341	CbGpPWpGaD
Chlorpromazine—CALM3—Hemostasis—NOS3—systemic scleroderma	2.08e-05	0.00034	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—HSPG2—systemic scleroderma	2.07e-05	0.000338	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—HSPG2—systemic scleroderma	2.07e-05	0.000338	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CSK—systemic scleroderma	2.07e-05	0.000337	CbGpPWpGaD
Chlorpromazine—CALM1—Hemostasis—NOS3—systemic scleroderma	2.02e-05	0.000329	CbGpPWpGaD
Chlorpromazine—CALM2—Hemostasis—NOS3—systemic scleroderma	2.02e-05	0.000329	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CSK—systemic scleroderma	2e-05	0.000326	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CSK—systemic scleroderma	2e-05	0.000326	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—EDN1—systemic scleroderma	1.99e-05	0.000325	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—EDN1—systemic scleroderma	1.96e-05	0.00032	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—CTGF—systemic scleroderma	1.95e-05	0.000319	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—CTGF—systemic scleroderma	1.94e-05	0.000317	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—HSPG2—systemic scleroderma	1.94e-05	0.000317	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—CCL2—systemic scleroderma	1.93e-05	0.000316	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—EDN1—systemic scleroderma	1.9e-05	0.00031	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—EDN1—systemic scleroderma	1.9e-05	0.00031	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—EDN1—systemic scleroderma	1.88e-05	0.000307	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—CTGF—systemic scleroderma	1.88e-05	0.000306	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—CTGF—systemic scleroderma	1.88e-05	0.000306	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HLA-DQB1—systemic scleroderma	1.88e-05	0.000306	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling by GPCR—CCL2—systemic scleroderma	1.87e-05	0.000305	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling by GPCR—CCL2—systemic scleroderma	1.86e-05	0.000304	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—EDN1—systemic scleroderma	1.85e-05	0.000303	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	1.83e-05	0.000298	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HLA-DQB1—systemic scleroderma	1.82e-05	0.000296	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HLA-DQB1—systemic scleroderma	1.82e-05	0.000296	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—NOS3—systemic scleroderma	1.8e-05	0.000294	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—MMP9—systemic scleroderma	1.79e-05	0.000293	CbGpPWpGaD
Chlorpromazine—ABCB11—Metabolism—NOS3—systemic scleroderma	1.79e-05	0.000292	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IL1A—systemic scleroderma	1.78e-05	0.000291	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—CCL2—systemic scleroderma	1.78e-05	0.000291	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—CD40LG—systemic scleroderma	1.77e-05	0.000289	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IL1A—systemic scleroderma	1.72e-05	0.000281	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IL1A—systemic scleroderma	1.72e-05	0.000281	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—NOS3—systemic scleroderma	1.72e-05	0.000281	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CD40LG—systemic scleroderma	1.71e-05	0.00028	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CD40LG—systemic scleroderma	1.71e-05	0.00028	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—CTGF—systemic scleroderma	1.68e-05	0.000274	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—CCL2—systemic scleroderma	1.64e-05	0.000268	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—EDN1—systemic scleroderma	1.62e-05	0.000264	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—CCL2—systemic scleroderma	1.62e-05	0.000264	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—CCL2—systemic scleroderma	1.61e-05	0.000263	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—EDN1—systemic scleroderma	1.61e-05	0.000262	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—CCL2—systemic scleroderma	1.61e-05	0.000262	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—CCL2—systemic scleroderma	1.6e-05	0.000261	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—CCL2—systemic scleroderma	1.59e-05	0.000259	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—CCL2—systemic scleroderma	1.58e-05	0.000258	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—HSPG2—systemic scleroderma	1.55e-05	0.000253	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—EDN1—systemic scleroderma	1.54e-05	0.000251	CbGpPWpGaD
Chlorpromazine—ADRA2A—Hemostasis—TGFB1—systemic scleroderma	1.51e-05	0.000246	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—CCL2—systemic scleroderma	1.49e-05	0.000244	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—CCL2—systemic scleroderma	1.49e-05	0.000243	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—TGFB1—systemic scleroderma	1.48e-05	0.000241	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—CTGF—systemic scleroderma	1.47e-05	0.00024	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—CCL2—systemic scleroderma	1.47e-05	0.00024	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—CCL2—systemic scleroderma	1.43e-05	0.000233	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—EDN1—systemic scleroderma	1.42e-05	0.000232	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—EDN1—systemic scleroderma	1.4e-05	0.000228	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—EDN1—systemic scleroderma	1.39e-05	0.000227	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—EDN1—systemic scleroderma	1.39e-05	0.000227	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—CTGF—systemic scleroderma	1.39e-05	0.000226	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—EDN1—systemic scleroderma	1.38e-05	0.000226	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—MMP9—systemic scleroderma	1.38e-05	0.000226	CbGpPWpGaD
Chlorpromazine—CALM3—Hemostasis—TGFB1—systemic scleroderma	1.38e-05	0.000225	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—EDN1—systemic scleroderma	1.37e-05	0.000224	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—EDN1—systemic scleroderma	1.37e-05	0.000223	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—CCL2—systemic scleroderma	1.36e-05	0.000222	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—CCL2—systemic scleroderma	1.34e-05	0.000219	CbGpPWpGaD
Chlorpromazine—CALM2—Hemostasis—TGFB1—systemic scleroderma	1.33e-05	0.000218	CbGpPWpGaD
Chlorpromazine—CALM1—Hemostasis—TGFB1—systemic scleroderma	1.33e-05	0.000218	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—NOS3—systemic scleroderma	1.33e-05	0.000217	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—NOS3—systemic scleroderma	1.33e-05	0.000217	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—NOS3—systemic scleroderma	1.31e-05	0.000214	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—CCL2—systemic scleroderma	1.3e-05	0.000212	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—CCL2—systemic scleroderma	1.3e-05	0.000212	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—CCL2—systemic scleroderma	1.28e-05	0.00021	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—NOS3—systemic scleroderma	1.27e-05	0.000208	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—EDN1—systemic scleroderma	1.27e-05	0.000207	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—CCL2—systemic scleroderma	1.27e-05	0.000207	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—NOS3—systemic scleroderma	1.21e-05	0.000198	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—HSPG2—systemic scleroderma	1.2e-05	0.000195	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—TGFB1—systemic scleroderma	1.19e-05	0.000194	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—CTGF—systemic scleroderma	1.17e-05	0.000192	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—EDN1—systemic scleroderma	1.16e-05	0.000189	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—NOS3—systemic scleroderma	1.15e-05	0.000187	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—TGFB1—systemic scleroderma	1.14e-05	0.000186	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—NOS3—systemic scleroderma	1.13e-05	0.000184	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—EDN1—systemic scleroderma	1.12e-05	0.000183	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—EDN1—systemic scleroderma	1.12e-05	0.000183	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—CCL2—systemic scleroderma	1.1e-05	0.00018	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—CCL2—systemic scleroderma	1.1e-05	0.000179	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—NOS3—systemic scleroderma	1.09e-05	0.000178	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—MMP9—systemic scleroderma	1.07e-05	0.000174	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—MMP9—systemic scleroderma	1.07e-05	0.000174	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—CCL2—systemic scleroderma	1.05e-05	0.000172	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—MMP9—systemic scleroderma	1.02e-05	0.000167	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—NOS3—systemic scleroderma	1.01e-05	0.000165	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—NOS3—systemic scleroderma	1.01e-05	0.000165	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—NOS3—systemic scleroderma	9.85e-06	0.000161	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—NOS3—systemic scleroderma	9.8e-06	0.00016	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—NOS3—systemic scleroderma	9.76e-06	0.000159	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—NOS3—systemic scleroderma	9.76e-06	0.000159	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—MMP9—systemic scleroderma	9.74e-06	0.000159	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CCL2—systemic scleroderma	9.7e-06	0.000158	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CCL2—systemic scleroderma	9.55e-06	0.000156	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CCL2—systemic scleroderma	9.53e-06	0.000155	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CCL2—systemic scleroderma	9.49e-06	0.000155	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CCL2—systemic scleroderma	9.46e-06	0.000154	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—NOS3—systemic scleroderma	9.38e-06	0.000153	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CCL2—systemic scleroderma	9.37e-06	0.000153	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CCL2—systemic scleroderma	9.35e-06	0.000153	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IL1B—systemic scleroderma	9.3e-06	0.000152	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—NOS3—systemic scleroderma	9.26e-06	0.000151	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—MMP9—systemic scleroderma	9.19e-06	0.00015	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—MMP9—systemic scleroderma	9.07e-06	0.000148	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CTGF—systemic scleroderma	9.06e-06	0.000148	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IL1B—systemic scleroderma	8.99e-06	0.000147	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IL1B—systemic scleroderma	8.99e-06	0.000147	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—TGFB1—systemic scleroderma	8.8e-06	0.000144	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—TGFB1—systemic scleroderma	8.79e-06	0.000143	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CCL2—systemic scleroderma	8.68e-06	0.000142	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—NOS3—systemic scleroderma	8.65e-06	0.000141	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—NOS3—systemic scleroderma	8.51e-06	0.000139	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—NOS3—systemic scleroderma	8.5e-06	0.000139	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—NOS3—systemic scleroderma	8.49e-06	0.000139	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—NOS3—systemic scleroderma	8.46e-06	0.000138	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—NOS3—systemic scleroderma	8.45e-06	0.000138	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—NOS3—systemic scleroderma	8.44e-06	0.000138	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—TGFB1—systemic scleroderma	8.41e-06	0.000137	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—NOS3—systemic scleroderma	8.35e-06	0.000136	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—NOS3—systemic scleroderma	8.33e-06	0.000136	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—NOS3—systemic scleroderma	8.17e-06	0.000133	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—NOS3—systemic scleroderma	8.17e-06	0.000133	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—TGFB1—systemic scleroderma	8.03e-06	0.000131	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CCL2—systemic scleroderma	7.92e-06	0.000129	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MMP9—systemic scleroderma	7.9e-06	0.000129	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MMP9—systemic scleroderma	7.86e-06	0.000128	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—NOS3—systemic scleroderma	7.74e-06	0.000126	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CCL2—systemic scleroderma	7.67e-06	0.000125	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CCL2—systemic scleroderma	7.67e-06	0.000125	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TGFB1—systemic scleroderma	7.57e-06	0.000124	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MMP9—systemic scleroderma	7.52e-06	0.000123	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TGFB1—systemic scleroderma	7.47e-06	0.000122	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—NOS3—systemic scleroderma	7.31e-06	0.000119	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NOS3—systemic scleroderma	7.06e-06	0.000115	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MMP9—systemic scleroderma	6.94e-06	0.000113	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NOS3—systemic scleroderma	6.83e-06	0.000112	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NOS3—systemic scleroderma	6.83e-06	0.000112	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MMP9—systemic scleroderma	6.83e-06	0.000111	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MMP9—systemic scleroderma	6.81e-06	0.000111	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MMP9—systemic scleroderma	6.79e-06	0.000111	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MMP9—systemic scleroderma	6.77e-06	0.00011	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MMP9—systemic scleroderma	6.7e-06	0.000109	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MMP9—systemic scleroderma	6.68e-06	0.000109	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—TGFB1—systemic scleroderma	6.67e-06	0.000109	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TGFB1—systemic scleroderma	6.51e-06	0.000106	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TGFB1—systemic scleroderma	6.48e-06	0.000106	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—TGFB1—systemic scleroderma	6.45e-06	0.000105	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—TGFB1—systemic scleroderma	6.45e-06	0.000105	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—NOS3—systemic scleroderma	6.4e-06	0.000104	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MMP9—systemic scleroderma	6.21e-06	0.000101	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TGFB1—systemic scleroderma	6.2e-06	0.000101	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—NOS3—systemic scleroderma	6.03e-06	9.85e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TGFB1—systemic scleroderma	5.72e-06	9.33e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MMP9—systemic scleroderma	5.67e-06	9.25e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TGFB1—systemic scleroderma	5.63e-06	9.18e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TGFB1—systemic scleroderma	5.61e-06	9.16e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TGFB1—systemic scleroderma	5.6e-06	9.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TGFB1—systemic scleroderma	5.58e-06	9.1e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TGFB1—systemic scleroderma	5.52e-06	9.02e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TGFB1—systemic scleroderma	5.51e-06	8.99e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MMP9—systemic scleroderma	5.48e-06	8.95e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MMP9—systemic scleroderma	5.48e-06	8.95e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TGFB1—systemic scleroderma	5.12e-06	8.35e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—NOS3—systemic scleroderma	5.11e-06	8.34e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TGFB1—systemic scleroderma	4.67e-06	7.62e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TGFB1—systemic scleroderma	4.52e-06	7.37e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TGFB1—systemic scleroderma	4.52e-06	7.37e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—NOS3—systemic scleroderma	3.94e-06	6.44e-05	CbGpPWpGaD
